Search results

|title=Distelmaier F, Koopman WJ, van den Heuvel LP, Rodenburg RJ, Mayatepek E, Willems PH, Smei |authors=Distelmaier F, Koopman WJ, van den Heuvel LP, Rodenburg RJ, Mayatepek E, Willems PH, Smei

|title=Distelmaier F, Valsecchi F, Forkink M, van Emst-de Vries S, Swarts HG, Rodenburg RJ, Verwiel ET, Smeit |authors=Distelmaier F, Valsecchi F, Forkink M, van Emst-de Vries S, Swarts HG, Rodenburg RJ, Verwiel ET, Smeit

...pman WJH.JPG|100px|left|Koopman Werner]] Bulthuis EP, Einer C, Distelmaier F, Groh L, van Emst-de Vries SE, van de Westerlo E, van de Wal M, Wagenaars |authors=Bulthuis EP, Einer C, Distelmaier F, Groh L, van Emst-de Vries SE, van de Westerlo E, van de Wal M, Wagenaars

# Koopman WJH, Distelmaier F, Smeitink JAM, Willems PHGM (2012) OXPHOS mutations and neurodegeneration. # Distelmaier F, Valsecchi F, Forkink M, van Emst-de Vries S, Swarts H, Rodenburg R, Verwiel E, Smeitink

# Koopman WJH, Distelmaier F, Smeitink JAM, Willems PHGM (2013) OXPHOS mutations and neurodegeneration. # Distelmaier F, Valsecchi F, Forkink M, Van Emst-de Vries S, Swarts H, Rodenburg R, Verwiel E, Smeitink

...g the electron transfer and phosphorylation systems including F₁F_o-ATP synthase. The most common OXPHOS disorder in humans is asso # Distelmaier F, Koopmann WJ, van den Heuvel PL, Rodenburg RJ, Mayatepek E, Willems PH, Sme

...edmann Angeli JP, Conrad M, Strom TM, Meitinger T, Prokisch H, Distelmaier F

# Distelmaier F, Koopman WJ, Van den Heuvel LP, Rodenburg RJ, Mayatepek E, Willems PH, Smei

...Martín-Fontecha M, Klugmann M, Guggenhuber S, Lutz B, Gertsch J, Chaouloff F, López-Rodríguez ML, Grandes P, Rossignol R, Marsicano G (2012) Mitochond # Distelmaier F, et al (2012) Trolox-sensitive ROS regulate mitochondrial morphology, oxida

:::: '''1.1. Ref 48''' Alzaid F, Patel VB, Preedy VR (2015) Biomarkers of oxidative stress in blood. In: Pr :::: '''1.21. Ref 65''' Fink BD, Bai F, Yu L, Sheldon RD, Sharma A, Taylor EB, Sivitz WI (2018) Oxaloacetic acid m